tiprankstipranks
Neurogene (NGNE)
NASDAQ:NGNE
US Market

Neurogene (NGNE) Technical Analysis

430 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Neurogene’s (NGNE) Moving Averages Convergence Divergence (MACD) indicator is 1.84, suggesting Neurogene is a Sell.
Neurogene’s (NGNE) 20-Day exponential moving average is 38.05, while Neurogene’s (NGNE) share price is $45.95, making it a Buy.
Neurogene’s (NGNE) 50-Day exponential moving average is 36.44, while Neurogene’s (NGNE) share price is $45.95, making it a Buy.

Neurogene (NGNE) Pivot Points

Jul 18, 2024, 01:34 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
37.86
39.37
40.98
42.49
44.09
45.60
47.21
Fibonacci
39.37
40.56
41.30
42.49
43.68
44.41
45.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neurogene (NGNE) Moving Averages

Jul 18, 2024, 01:34 PM
Period
Simple
Exponential
MA5
41.43Buy
42.06Buy
MA10
39.31Buy
39.88Buy
MA20
36.71Buy
38.05Buy
MA50
35.50Buy
36.44Buy
MA100
36.58Buy
34.46Buy
MA200
28.01Buy
27.84Buy
Neurogene’s (NGNE) 10-Day exponential moving average is 39.88, while Neurogene’s (NGNE) share price is $45.95, making it a Buy.
Neurogene’s (NGNE) 100-Day exponential moving average is 34.46, while Neurogene’s (NGNE) share price is $45.95, making it a Buy.
Neurogene’s (NGNE) stock price is $45.95 and Neurogene’s (NGNE) 50-day simple moving average is 35.50, creating a Buy signal.
Neurogene’s (NGNE) stock price is $45.95 and Neurogene’s (NGNE) 100-day simple moving average is 36.58, creating a Buy signal.
Neurogene’s (NGNE) stock price is $45.95 and Neurogene’s (NGNE) 200-day simple moving average is 28.01, creating a Buy signal.

Neurogene (NGNE) Technical Indicators

Jul 18, 2024, 01:34 PM
Name
Value
Implied Action
RSI (14)
67.43
Neutral
STOCH (9,6)
82.74
Sell
STOCHRSI (14)
86.75
Sell
MACD (12,26)
1.84
Sell
ADX (14)
25.24
Neutral
Williams %R
-16.40
Sell
CCI (14)
154.97
Sell
ATR (14)
3.66
-
Ultimate Oscillator
53.57
Neutral
ROC
44.72
Buy
Neurogene’s (NGNE) Relative Strength Index (RSI) is 67.43, creating a Neutral signal.
Neurogene’s (NGNE) Trend Strength Indicator (ADX) is 25.24, creating a Neutral signal.
Neurogene’s (NGNE) Commodity Channel Index (CCI) is 154.97, creating a Sell signal.
Neurogene’s (NGNE) Price Rate of Change (ROC) is 44.72, creating a Buy signal.

FAQ

Is NGNE a Buy, Hold, or Sell?
Based on NGNE’s technical indicators, NGNE is a Buy.
    What is NGNE’s RSI (14)?
    NGNE’s RSI (14) is 67.43, which suggests NGNE is a Neutral.
      What is NGNE’s MACD?
      NGNE’s MACD is 1.84, which suggests NGNE is a Sell.
        What is NGNE’s 5-day moving average?
        NGNE’s 5-day moving average is 41.43, which suggests NGNE is a Buy.
          What is NGNE’s 20-day moving average?
          NGNE 20-day moving average is 36.71, which suggests NGNE is a Buy.
            What is NGNE’s 50-day moving average?
            NGNE’s 50-day moving average is 35.50, which suggests NGNE is a Buy.
              What is NGNE’s 200-day moving average?
              NGNE’s 200-day moving average is 28.01, which suggests NGNE is a Buy.
                What is NGNE’s Williams % R (14)?
                NGNE’s Williams % R (14) is -16.40, which suggests NGNE is a Sell.
                  What is NGNE’s CCI (14)?
                  NGNE’s CCI (14) is 154.97, which suggests NGNE is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis